Estimating the financial cost of chronic kidney disease to the NHS in England

Background Chronic kidney disease (CKD) is a major challenge for health care systems around the world, and the prevalence rates appear to be increasing. We estimate the costs of CKD in a universal health care system. Methods Economic modelling was used to estimate the annual cost of Stages 3–5 CKD to the National Health Service (NHS) in England, including CKD-related prescribing and care, renal replacement therapy (RRT), and excess strokes, myocardial infarctions (MIs) and Methicillin-Resistant Staphylococcus Aureus (MRSA) infections in people with CKD. Results The cost of CKD to the English NHS in 2009–10 is estimated at £1.44 to £1.45 billion, which is ∼1.3% of all NHS spending in that year. More than half this sum was spent on RRT, which was provided for 2% of the CKD population. The economic model estimates that ∼7000 excess strokes and 12 000 excess MIs occurred in the CKD population in 2009–10, relative to an age- and gender-matched population without CKD. The cost of excess strokes and MIs is estimated at £174–£178 million. Conclusions The financial impact of CKD is large, with particularly high costs relating to RRT and cardiovascular complications. It is hoped that these detailed cost estimates will be useful in analysing the cost-effectiveness of treatments for CKD.

[1]  K. Iseki,et al.  Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. , 1993, Kidney international.

[2]  Wallace N. Atherton,et al.  Third annual report , 1961 .

[3]  Supplemental Tables,et al.  KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). , 2009, Kidney international. Supplement.

[4]  M. Fukagawa,et al.  Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). , 2008, Internal medicine.

[5]  Debbie Andalo,et al.  Innovation and improvement. , 2006, Nursing management.

[6]  Deeb N Salem,et al.  Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. , 2004, Journal of the American Society of Nephrology : JASN.

[7]  Madhavi Bajekal,et al.  Health Survey for England , 2004 .

[8]  C. Meisinger,et al.  Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. , 2006, European heart journal.

[9]  A. Macleod,et al.  Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD) , 2009 .

[10]  G. Eknoyan,et al.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  C. Mathers,et al.  Stroke incidence and prevalence in Europe: a review of available data , 2006, European journal of neurology.

[12]  A. M. Nahas,et al.  The burden of chronic kidney disease , 2006, BMJ : British Medical Journal.

[13]  The current and future roles of NHS Networks, NHS Live and Contact, Help, Advice and Information Network (CHAIN) in supporting the Strategic Objectives of the NHS Institute for Innovation and Improvement , 2008 .

[14]  Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών. Σχολή Νομικών,et al.  Ετήσια εσωτερική (απογραφική) έκθεση για το ακαδημαϊκό έτος 2009-10 , 2011 .

[15]  J. Mindell,et al.  Kidney disease and renal function , 2010 .

[16]  A. Cumming,et al.  Diarrhoea due to Clostridium difficile associated with antibiotic treatment in patients receiving dialysis: the role of cross infection. , 1986, British medical journal.

[17]  J. Griffith,et al.  Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney disease. , 2007, Journal of the American Society of Nephrology : JASN.

[18]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[19]  Piotr Spiewanowski,et al.  The cost of renal dialysis in a UK setting--a multicentre study. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  C. Schmid,et al.  Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease , 2001, Annals of Internal Medicine.

[21]  S. de Lusignan,et al.  Creatinine Fluctuation Has a Greater Effect than the Formula to Estimate Glomerular Filtration Rate on the Prevalence of Chronic Kidney Disease , 2010, Nephron Clinical Practice.

[22]  S de Lusignan,et al.  Chronic kidney disease management in the United Kingdom: NEOERICA project results. , 2007, Kidney international.

[23]  James A. Roberts,et al.  Socio-economic burden of hospital acquired infection , 1999 .

[24]  R. Ward NHS Kidney Care , 2011 .

[25]  Maya K. Rao Chronic Kidney Disease: National Clinical Guideline for Early Identification and Management in Adults in Primary and Secondary Care , 2009 .

[26]  C. Schmid,et al.  Erratum: Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease (Annals of Internal Medicine (2001) 135 (73-87)) , 2002 .

[27]  T. Feest,et al.  Management of anaemia in United Kingdom renal units: a report from the UK Renal Registry. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  L. Vale,et al.  DIALYSIS FOR END-STAGE RENAL DISEASE , 2001, International Journal of Technology Assessment in Health Care.

[29]  A. Dhar,et al.  National Institute for Health and Clinical Excellence , 2005 .

[30]  T. Kovithavongs Clostridium difficile colitis associated with chronic renal failure. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.